market impact
pharma
Wipro Acquisition Delay: A Clear Overview of the Impact
Wipro acquisition delay highlights significant changes in consulting contracts set for December 31.
Read More
pharma
Sudarshan Pharma stake acquisition: Is it the best move?
Sudarshan Pharma stake acquisition is under due diligence for a 9.5% share in a US firm, raising questions about its potential impact.
Read More